RFK Jr. and Trump's Executive Order on Prescription Drug Costs

US Prescription Drug Pricing Issues

• 🇺🇸 Americans pay significantly higher prices for prescription drugs and healthcare compared to other countries.
• 💊 This is attributed to the removal of the patient from the equation, the role of pharmacy benefit managers inflating prices, and costly FDA regulatory processes.
• 📈 High prices are seen as a signal for drug manufacturers to recoup costs for drugs that may fail during development.

International Drug Pricing and Controls

• 🌍 Other countries have lower drug prices due to strict government-enforced price controls.
• ⚠️ However, these price controls can lead to drug shortages and less access to certain medications in those nations.
• ⚖️ The US system involves more middlemen and buyers, such as health plans and insurance companies, unlike the government-centric approach in other countries.

Trump's Executive Order and 'Most Favored Nation' Policy

• 📝 President Trump signed an executive order to align US prescription drug prices with the lowest prices found in other countries, aiming for pricing equity.
• 🏛️ This 'Most Favored Nation' policy aims to reduce costs for US consumers, particularly for Medicare and Medicaid.
• ⚖️ The legality of a similar previous order was challenged and struck down in courts, raising questions about the current order's effectiveness.

Impact on Drug Research and Development

• 🔬 Drug manufacturers have expressed concerns that tying prices to international benchmarks could reduce revenues.
• 📉 This potential reduction in revenue could lead to fewer new drugs being researched and brought to market.

Timeline for Lower Drug Costs

• 🗓️ HHS Secretary RFK Jr. is tasked with negotiating prices with drug manufacturers.
• ⏳ A six-month period from the order's signing (May) is allocated for these negotiations and for manufacturers to adjust to negotiated prices.
• 🚀 If negotiations fail, the administration may enact prices through rulemaking authority, potentially by the end of 2025 or early 2026.